Mattocks A R, White I N
Chem Biol Interact. 1976 Oct 2;15(2):173-84. doi: 10.1016/0009-2797(76)90162-9.
An intravenous dose of 40 mg/kg [3H] synthanecine A bis-N-ethylcarbamate, sufficient to cause liver lesions similar to pyrrolizidine alkaloid poisoning, was given to male rats. The distribution of radioactivity in body tissues was measured after various times from 2 h to 340 days. About 69% of the dose was eliminated via urine and faeces on the first day, while less than 0.4% was found in expired air. The highest tissue level of radioactivity was initially in liver, but this fell steadily at a rate comparable with most other tissues. High levels were also found in kidneys, spleen and lungs, and elimination from the latter was exceptionally slow. A high level in the erythrocytes probably accounted for a persistence of radioactivity in the spleen. Ehrlich estimations showed that 68% of the radioactivity in the liver 2--6 h after dosing was present as pyrrolic metabolites. A high proportion of the liver activity was not extractable by alcohol or aqueous trichloroacetic acid. Binding in the microsomal and nuclear fractions of liver was surprisingly low. From the low level of radioactivity in stomach tissue it was concluded that 2,3-bishydroxymethyl-1-methyl pyrrole could not have been a major metabolite in the bloodstream, since the latter, when given intravenously, binds strongly to the glandular stomach.
给雄性大鼠静脉注射40毫克/千克[3H]合成千里光碱A双-N-乙基氨基甲酸酯,该剂量足以引发类似于吡咯里西啶生物碱中毒的肝脏损伤。在给药后2小时至340天的不同时间点,测定了放射性在动物体组织中的分布情况。给药第一天,约69%的剂量通过尿液和粪便排出,而呼出气体中的放射性不到0.4%。放射性在组织中的最高水平最初出现在肝脏,但随后与大多数其他组织一样以稳定的速率下降。在肾脏、脾脏和肺中也发现了较高水平的放射性,且从肺中排出的速度异常缓慢。红细胞中的高水平放射性可能是脾脏中放射性持续存在的原因。埃利希测定法显示,给药后2至6小时,肝脏中68%的放射性以吡咯代谢物的形式存在。肝脏中的大部分活性物质不能被酒精或三氯乙酸水溶液提取。肝脏微粒体和细胞核部分的结合率出奇地低。鉴于胃组织中的放射性水平较低,得出的结论是,2,3-二羟甲基-1-甲基吡咯不可能是血液中的主要代谢产物,因为静脉注射该物质时,它会与腺胃强烈结合。